StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
100
This year
2
Publishing Date
2022 - 12 - 13
2
2022 - 08 - 15
2
2022 - 07 - 01
1
2022 - 06 - 22
1
2022 - 05 - 16
1
2022 - 05 - 09
1
2022 - 05 - 05
1
2022 - 04 - 27
1
2022 - 04 - 26
1
2022 - 04 - 20
1
2022 - 03 - 25
1
2022 - 03 - 21
1
2022 - 03 - 16
2
2022 - 03 - 04
1
2022 - 02 - 28
1
2022 - 02 - 25
1
2022 - 02 - 16
1
2022 - 02 - 09
1
2022 - 01 - 25
1
2022 - 01 - 24
1
2021 - 12 - 21
1
2021 - 12 - 16
1
2021 - 12 - 13
1
2021 - 11 - 22
1
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 16
1
2021 - 10 - 27
1
2021 - 10 - 22
1
2021 - 10 - 21
2
2021 - 10 - 12
2
2021 - 09 - 22
2
2021 - 09 - 15
1
2021 - 09 - 08
1
2021 - 08 - 10
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 08 - 02
2
2021 - 07 - 30
1
2021 - 07 - 28
1
2021 - 07 - 26
1
2021 - 07 - 22
1
2021 - 07 - 20
1
2021 - 06 - 02
1
2021 - 05 - 20
1
2021 - 05 - 03
3
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 19
2
2021 - 03 - 29
1
2021 - 03 - 15
1
2021 - 03 - 03
1
2021 - 01 - 13
1
2020 - 12 - 10
1
2020 - 12 - 04
1
2020 - 10 - 14
1
2020 - 10 - 12
1
2020 - 09 - 30
1
2020 - 09 - 11
1
Sector
Health technology
100
Manufacturing
7
N/a
3
Process industries
1
Professional, scientific, and technical services
4
Tags
Acquire
2
Alliances
6
Als
1
America
1
Antibody
4
Application
2
Approval
5
Arct-154
5
Authorized
2
Biotech
4
Biotech-bay
2
Biotech-beach
12
Cancer
5
Clinical-trials-phase-ii
5
Collaboration
6
Commercialization
3
Conference
2
Covid
3
Disease
4
Drug
4
Earnings
4
Expected
2
Financial
3
Financial results
6
Funding
2
Genetown
2
Global
11
Grant
3
Granted
2
Growth
6
Iot
2
Israel
2
License
2
Market
23
Mergers-and-acquisitions
2
Money
3
N/a
46
Narcolepsy
2
Nash
2
People
3
Phase 1
2
Phase 2
3
Phase 3
5
Pons
2
Potential
3
Product-news
2
Program
2
Rare
3
Report
16
Research
13
Response
3
Results
13
Sars-cov-2
6
Syndros
2
Technology
2
Therapeutics
37
Therapy
8
Treatment
6
Trial
7
Vaccine
7
Entities
Abbvie inc.
156
Abeona therapeutics inc.
116
Adc therapeutics sa
145
Addex therapeutics ltd
101
Akebia therapeutics, inc.
117
Akero therapeutics, inc.
104
Aldeyra therapeutics, inc.
123
Allogene therapeutics, inc.
177
Alphabet inc.
198
Alterity therapeutics limited
106
Amarin corporation plc
139
Amgen inc.
137
Aquestive therapeutics, inc.
147
Astrazeneca plc
118
Autolus therapeutics plc
105
Axsome therapeutics, inc.
116
Biogen inc.
104
Bioxcel therapeutics, inc.
169
Brainstorm cell therapeutics inc.
131
Bristol-myers squibb company
131
Calliditas therapeutics ab
142
Denali therapeutics inc.
104
Eli lilly and company
284
Fate therapeutics, inc.
256
Fulcrum therapeutics, inc.
134
G1 therapeutics, inc.
136
Gilead sciences, inc.
107
Glaxosmithkline plc
151
Horizon therapeutics public limited company
146
Hoth therapeutics, inc.
109
Intellia therapeutics, inc.
112
Johnson & johnson
531
Karyopharm therapeutics inc.
166
Lineage cell therapeutics, inc.
109
Medicenna therapeutics corp.
109
Morgan stanley
209
Morphosys ag
191
Nektar therapeutics
371
Novartis ag
226
Nurix therapeutics, inc.
147
Oncocyte corporation
183
Onconova therapeutics, inc.
114
Outlook therapeutics, inc.
148
Plus therapeutics, inc.
124
Poseida therapeutics, inc.
110
Ptc therapeutics, inc.
271
Relief therapeutics holding sa
109
Sanofi
712
Sarepta therapeutics, inc.
165
Seres therapeutics, inc.
116
Sorrento therapeutics, inc.
229
Spero therapeutics, inc.
121
Tg therapeutics, inc.
148
Therapeuticsmd, inc.
195
Travere therapeutics inc.
122
United therapeutics corporation
144
Vaxart, inc.
186
Vistagen therapeutics, inc.
116
Vyne therapeutics inc.
172
Y-mabs therapeutics, inc.
178
Symbols
ABBV
8
ABT
2
ADCT
1
ADMA
1
ADXN
1
AFMD
1
AGIO
1
ALKS
1
ALNY
1
ALPMF
3
ALPMY
3
AMGN
7
ARCT
26
AUPH
1
AZN
8
AZNCF
8
BAX
1
BEAM
1
BMRN
1
BMY
12
BNTX
2
BSX
2
CLDX
1
DD
1
DNAA
1
EIGR
2
EXEL
2
FNCH
2
FOLD
2
GBT
3
GILD
6
GKOS
2
GLAXF
6
GSK
7
JAZZ
2
JNJ
41
KPTI
7
LLY
11
LOGC
4
MNK
2
MNKKQ
2
MNKPF
2
NBIX
3
NKTR
3
NKTX
2
NVO
4
NVS
15
NVSEF
14
OVID
6
PFE
8
PSTX
2
REGN
4
SNY
19
SNYNF
16
TAK
100
TEVJF
6
UCBJF
3
UCBJY
3
VYGR
2
YMAB
2
Exchanges
Amex
1
Nasdaq
89
Nyse
100
Crawled Date
2022 - 12 - 13
2
2022 - 08 - 25
1
2022 - 08 - 15
2
2022 - 08 - 11
1
2022 - 08 - 05
1
2022 - 07 - 11
1
2022 - 07 - 01
1
2022 - 06 - 22
1
2022 - 05 - 16
1
2022 - 05 - 09
1
2022 - 05 - 05
1
2022 - 04 - 27
1
2022 - 04 - 26
1
2022 - 04 - 20
1
2022 - 03 - 25
1
2022 - 03 - 21
1
2022 - 03 - 16
2
2022 - 03 - 04
1
2022 - 02 - 28
1
2022 - 02 - 25
1
2022 - 02 - 16
1
2022 - 02 - 09
1
2022 - 01 - 25
1
2022 - 01 - 24
1
2021 - 12 - 21
1
2021 - 12 - 16
1
2021 - 12 - 13
1
2021 - 11 - 22
1
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 16
1
2021 - 10 - 27
1
2021 - 10 - 22
1
2021 - 10 - 21
2
2021 - 10 - 12
2
2021 - 09 - 22
2
2021 - 09 - 15
1
2021 - 09 - 08
1
2021 - 08 - 10
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 08 - 02
2
2021 - 07 - 30
1
2021 - 07 - 28
1
2021 - 07 - 26
1
2021 - 07 - 22
1
2021 - 07 - 20
1
2021 - 06 - 02
1
2021 - 05 - 20
1
2021 - 05 - 03
3
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 19
2
2021 - 03 - 29
1
2021 - 03 - 15
1
2021 - 03 - 04
5
2021 - 01 - 13
1
2020 - 12 - 10
1
2020 - 12 - 04
1
Crawled Time
01:00
1
02:00
2
04:00
1
07:00
1
09:00
4
10:00
1
10:48
5
11:00
3
12:00
12
12:15
2
12:20
2
13:00
12
13:20
2
13:30
3
14:00
10
14:02
1
14:15
1
14:20
4
14:30
2
15:00
6
15:20
1
15:30
2
16:00
1
17:00
3
18:00
3
20:00
2
21:00
3
22:00
6
23:00
4
Source
investors.ovidrx.com
6
www.biospace.com
53
www.globenewswire.com
4
www.prnewswire.com
37
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
entities :
Takeda pharmaceutical company limited
save search
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-7.74%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.22%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-7.87%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
-1.12%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-6.94%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-2.03%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
-5.47%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.54%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published:
2024-01-26
(Crawled : 15:30)
- prnewswire.com
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-9.57%
|
O:
-0.27%
H:
0.38%
C:
0.07%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.08%
|
O:
0.29%
H:
0.15%
C:
-0.13%
SRPT
|
$124.27
6.11%
5.75%
1.3M
|
Health Technology
|
3.52%
|
O:
0.69%
H:
0.12%
C:
-1.75%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-16.39%
|
O:
0.0%
H:
0.35%
C:
-0.88%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-12.01%
|
O:
0.1%
H:
0.47%
C:
0.39%
market
Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published:
2023-11-27
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.91%
|
O:
-1.89%
H:
0.02%
C:
0.02%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.76%
|
O:
-4.49%
H:
6.23%
C:
3.42%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
23.66%
|
O:
-0.21%
H:
0.21%
C:
-1.93%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-5.97%
|
O:
-0.07%
H:
0.28%
C:
0.21%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
4.07%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
VNDA
|
$4.57
-1.3%
-1.31%
1.5M
|
Health Technology
|
28.09%
|
O:
2.81%
H:
0.0%
C:
-3.01%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.43%
|
O:
-1.41%
H:
0.87%
C:
0.0%
america
therapeutics
growth
market
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.11%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.555
-0.06%
-0.06%
590K
|
Health Technology
|
21.79%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-3.08%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
612.26%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
17.78%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
|
$3.47
-6.72%
-7.2%
540K
|
Health Technology
|
34.5%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
News
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-16.35%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
12.8%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors
Published:
2023-10-03
(Crawled : 20:00)
- globenewswire.com
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-11.51%
|
O:
-2.07%
H:
0.19%
C:
-0.07%
LRMR
|
$6.46
0.0%
220K
|
Health Technology
|
81.72%
|
O:
-1.27%
H:
0.0%
C:
-2.42%
HZNP
|
$116.3
0.03%
29M
|
Health Technology
|
0.06%
|
O:
-0.0%
H:
0.03%
C:
0.02%
therapeutics
Global Human Microbiome Therapeutic Market Set to Reach $3.4 Billion by 2030: Unleashing the Potential of Microbiome-based Therapies
Published:
2023-07-18
(Crawled : 02:00)
- prnewswire.com
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-13.36%
|
O:
0.85%
H:
0.75%
C:
0.19%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-6.87%
|
O:
0.0%
H:
1.14%
C:
-0.01%
DD
|
News
|
$73.96
0.22%
0.0%
1.5M
|
Process Industries
|
1.9%
|
O:
0.7%
H:
2.13%
C:
2.0%
MCRB
|
$0.7295
-4.01%
-4.18%
5.8M
|
Health Technology
|
-84.63%
|
O:
-0.21%
H:
4.43%
C:
1.48%
EVLO
|
$0.3165
-87.39%
710K
|
Health Technology
|
-91.08%
|
O:
4.79%
H:
63.71%
C:
54.3%
reach
global
set
potential
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$24.66
1.65%
1.62%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$128.725
-39.66%
750
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-7.86%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
17.13%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-17.78%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.15%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
18.92%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
72.38%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-25.02%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-19.49%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-2.88%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
23.39%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-7.31%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-8.36%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
18.53%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-16.74%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-30.9%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
-20.14%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
1.28%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-24.46%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-5.56%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-2.25%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published:
2023-05-15
(Crawled : 17:00)
- prnewswire.com
GNMSF
|
News
|
$290.34
3.83%
340
|
Health Technology
|
-33.48%
|
O:
0.24%
H:
0.66%
C:
0.66%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
10.61%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-19.23%
|
O:
0.61%
H:
0.3%
C:
0.24%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.64%
|
O:
0.2%
H:
0.13%
C:
-0.22%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
11.85%
|
O:
0.27%
H:
0.6%
C:
0.41%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.29%
|
O:
0.38%
H:
0.0%
C:
0.0%
GMAB
|
News
|
$28.47
-0.32%
-0.32%
460K
|
Health Technology
|
-31.71%
|
O:
0.38%
H:
0.91%
C:
0.69%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
17.2%
|
O:
0.14%
H:
0.28%
C:
0.11%
report
cancer
global
therapy
growth
market
Neurocrine Biosciences Reports First Quarter 2023 Financial Results
Published:
2023-05-03
(Crawled : 12:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-20.4%
|
O:
0.36%
H:
0.57%
C:
0.18%
VYGR
|
News
|
$7.57
-1.05%
-1.06%
310K
|
Health Technology
|
9.08%
|
O:
5.76%
H:
6.4%
C:
5.04%
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
34.34%
|
O:
3.43%
H:
0.92%
C:
-7.83%
financial
results
Plasma Protein Therapeutics Market to Reach $44,296.78 million, Globally, by 2031 at 5.2% CAGR: Allied Market Research
Published:
2023-04-12
(Crawled : 09:00)
- prnewswire.com
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-20.01%
|
O:
0.91%
H:
0.36%
C:
-0.42%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
-4.57%
|
O:
0.47%
H:
0.8%
C:
-0.97%
GRFS
|
$6.4
-1.23%
-1.25%
960K
|
Health Technology
|
-14.57%
|
O:
4.55%
H:
0.0%
C:
-4.35%
ADMA
4
|
$6.465
-1.15%
-1.16%
1.7M
|
Health Technology
|
100.0%
|
O:
3.1%
H:
0.0%
C:
-6.31%
research
protein
therapeutics
market
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides Financial Expectations for 2023
Published:
2023-02-06
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-17.16%
|
O:
-0.94%
H:
0.51%
C:
-0.13%
VYGR
|
News
|
$7.57
-1.05%
-1.06%
310K
|
Health Technology
|
-6.54%
|
O:
-1.11%
H:
3.87%
C:
0.5%
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
26.3%
|
O:
-5.23%
H:
6.35%
C:
0.71%
financial
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published:
2023-01-30
(Crawled : 17:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
4.26%
|
O:
1.09%
H:
2.18%
C:
-1.43%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-17.47%
|
O:
-0.19%
H:
0.13%
C:
-0.69%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-40.01%
|
O:
0.0%
H:
0.79%
C:
-0.55%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-11.94%
|
O:
-0.18%
H:
0.36%
C:
-3.53%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-2.78%
|
O:
-0.13%
H:
0.78%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
8.65%
|
O:
1.3%
H:
0.06%
C:
-0.81%
global
report
gastrointestinal
therapeutics
market
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published:
2023-01-18
(Crawled : 12:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-94.91%
|
O:
-0.13%
H:
3.25%
C:
-3.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
25.97%
|
O:
0.05%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-18.08%
|
O:
0.62%
H:
0.12%
C:
-0.68%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-42.99%
|
O:
-1.16%
H:
0.67%
C:
-1.2%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
6.46%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-14.05%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
110.27%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
SUPN
|
$30.26
1.04%
1.02%
200K
|
Health Technology
|
-24.5%
|
O:
0.07%
H:
2.69%
C:
0.32%
market
Global Head And Neck Cancer Therapeutics Market Report 2022: Sector to Reach $2.5 Billion by 2028 at a 12.3% CAGR
Published:
2023-01-12
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-5.39%
|
O:
-0.13%
H:
0.76%
C:
0.76%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-2.39%
|
O:
2.77%
H:
0.63%
C:
0.63%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-15.95%
|
O:
0.13%
H:
2.35%
C:
2.16%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
109.46%
|
O:
0.13%
H:
1.04%
C:
0.57%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-1.9%
|
O:
1.89%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
1.6%
|
O:
1.27%
H:
0.78%
C:
0.15%
global
report
therapeutics
cancer
market
Natural Killer Cells Therapeutics Global Market Report 2022: Growing Focus of BioTech and Pharma Companies on Cost-Effective and Potent Treatments Boosts Sector
Published:
2022-12-28
(Crawled : 13:00)
- prnewswire.com
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
-15.34%
|
O:
4.47%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.53%
|
O:
2.43%
H:
0.0%
C:
-0.57%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-14.2%
|
O:
0.13%
H:
0.58%
C:
-0.26%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-1.93%
|
O:
-0.4%
H:
0.0%
C:
0.0%
NKTX
|
$7.16
-5.29%
-5.59%
680K
|
Health Technology
|
39.49%
|
O:
0.0%
H:
6.03%
C:
2.33%
FATE
|
News
|
$4.3
-5.29%
-5.58%
2M
|
Health Technology
|
-57.84%
|
O:
-0.59%
H:
2.96%
C:
-2.76%
AFMD
|
$4.91
-8.22%
-8.96%
65K
|
Health Technology
|
335.71%
|
O:
1.79%
H:
3.51%
C:
0.0%
pharma
global
companies
report
growing
biotech
natural
therapeutics
market
Global Rare Disease Drugs Market Report 2022-2027: Increasing Focus on Research Activities and Development of Novel Therapeutic Drugs to Facilitate Future Growth
Published:
2022-12-15
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.48%
|
O:
-0.85%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-14.15%
|
O:
-0.71%
H:
0.07%
C:
-1.05%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
6.29%
|
O:
-0.71%
H:
0.08%
C:
-1.07%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
1.78%
|
O:
-0.59%
H:
0.44%
C:
-0.48%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.33%
|
O:
0.04%
H:
0.0%
C:
0.0%
rare
research
global
disease
report
growth
market
Takeda to Acquire Nimbus Therapeutics’ Highly Selective, Allosteric TYK2 Inhibitor to Address Multiple Immune-Mediated Diseases
Published:
2022-12-13
(Crawled : 13:20)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-11.33%
|
O:
2.21%
H:
0.66%
C:
-0.07%
acquire
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
Published:
2022-12-13
(Crawled : 12:20)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-11.33%
|
O:
2.21%
H:
0.66%
C:
-0.07%
ndi-0348
acquire
therapeutics
potential
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.